sanofi featured image
News Pharmaceutical & Biotech Stories

Sanofi Will Help Make Moderna’s Vaccine in U.S.

April 26, Monday, drugmaker Sanofi said it would help make Moderna’s COVID-19 vaccine, its third collaboration with another drugmaker on COVID-19 vaccine manufacturing.

The drugmaker signed an agreement to help manufacture as many as 200 million doses of Moderna Inc.’s COVID-19 vaccine in the U.S. starting in September.

According to Sanofi’s British CEO Paul Hudson, “We are one of the few pharmaceutical companies to leverage many industrial partnerships to improve global supply and access to COVID-19 vaccines, while in parallel, also continuing to develop our two COVID19 vaccine programs.”

Moderna’s vaccine is based on the same messenger RNA technology that Sanofi hopes to use for its own COVID shots after its initial efforts were called off because of disappointing trial results.

Moderna is aiming to produce one billion doses of its COVID-19 vaccine by the end of this year and hopes to increase output to 1.4 billion doses next year.

ASEAN HR TECH VENTURE SUMMIT 2018
REGISTER NOW 33% DISCOUNT
SUMMIT PASS